Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.880
-0.030 (-1.03%)
At close: Aug 26, 2026, 4:00 PM EDT
2.885
+0.005 (0.17%)
After-hours: Aug 26, 2026, 7:44 PM EDT
Ovid Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 11.33 | 13.15 | 26.3 | 27.04 | 44.87 | 187.8 |
Short-Term Investments | 105.89 | 56.48 | 26.77 | 78.79 | 84.13 | - |
Cash & Short-Term Investments | 117.22 | 69.64 | 53.08 | 105.83 | 129 | 187.8 |
Cash Growth | 205.68% | 31.20% | -49.85% | -17.96% | -31.31% | 160.71% |
Prepaid Expenses | 6.4 | 4.73 | 2.87 | 3.76 | 2.38 | 2.68 |
Other Current Assets | - | - | - | 0 | - | - |
Total Current Assets | 123.62 | 74.37 | 55.94 | 109.6 | 131.38 | 190.48 |
Property, Plant & Equipment | 11.18 | 11.86 | 13.23 | 14.66 | 16.07 | 0.24 |
Long-Term Investments | 95.24 | 62.77 | 20.97 | 17.63 | 5.62 | 1.63 |
Other Intangible Assets | - | - | 0.09 | 0.2 | 0.22 | 0.26 |
Other Long-Term Assets | 1.93 | 1.93 | 1.93 | 1.94 | 1.97 | 1.93 |
Total Assets | 231.97 | 150.93 | 92.17 | 144.03 | 155.27 | 194.54 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 4.07 | 1.96 | 3.19 | 3.7 | 1.95 | 7.13 |
Accrued Expenses | 4.24 | 4.9 | 5.99 | 6.52 | 4.5 | 7.67 |
Current Portion of Leases | 1.48 | 1.43 | 1.34 | 1.25 | 0.53 | - |
Total Current Liabilities | 9.98 | 8.29 | 10.52 | 11.47 | 6.99 | 14.8 |
Long-Term Leases | 11.23 | 11.99 | 13.42 | 14.76 | 16 | - |
Other Long-Term Liabilities | 0.87 | - | - | 30 | - | - |
Total Liabilities | 22.08 | 20.27 | 23.94 | 56.23 | 22.99 | 14.8 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.19 | 0.13 | 0.07 | 0.07 | 0.07 | 0.07 |
Additional Paid-In Capital | 564.17 | 452.45 | 372.49 | 365.59 | 357.77 | 351.03 |
Retained Earnings | -353.71 | -321.71 | -304.3 | -277.87 | -225.53 | -171.36 |
Comprehensive Income & Other | -0.75 | -0.2 | -0.04 | - | -0.04 | - |
Total Common Equity | 209.89 | 130.66 | 68.23 | 87.8 | 132.27 | 179.75 |
Shareholders' Equity | 209.89 | 130.66 | 68.23 | 87.8 | 132.27 | 179.75 |
Total Liabilities & Equity | 231.97 | 150.93 | 92.17 | 144.03 | 155.27 | 194.54 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 12.72 | 13.42 | 14.76 | 16 | 16.54 | - |
Net Cash (Debt) | 157.05 | 77.03 | 38.32 | 89.83 | 112.47 | 187.8 |
Net Cash Growth | 547.70% | 101.01% | -57.34% | -20.13% | -40.11% | 160.71% |
Net Cash Per Share | 1.29 | 1.04 | 0.54 | 1.27 | 1.60 | 2.76 |
Filing Date Shares Outstanding | 195.3 | 131.87 | 71.08 | 70.71 | 70.49 | 70.37 |
Total Common Shares Outstanding | 184.76 | 130.18 | 71.01 | 70.69 | 70.47 | 70.36 |
Working Capital | 113.64 | 66.08 | 45.42 | 98.13 | 124.39 | 175.68 |
Book Value Per Share | 1.14 | 1.00 | 0.96 | 1.24 | 1.88 | 2.55 |
Tangible Book Value | 209.89 | 130.66 | 68.13 | 87.6 | 132.05 | 179.49 |
Tangible Book Value Per Share | 1.14 | 1.00 | 0.96 | 1.24 | 1.87 | 2.55 |
Machinery | 1.53 | 1.53 | 1.53 | 1.46 | 1.42 | 0.5 |
Leasehold Improvements | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | - |